Relevant scientific works
The Florence Medical Association has published an important document on antibiotic prophylaxis in dentistry, with particular attention to patients with cardiomyopathy. The document emphasizes that the use of antibiotics must be carefully evaluated to avoid the growing problem of antibiotic resistance.
In patients with cardiac implantable electronic devices (CIEDs) (implantable cardioverter-defibrillators [ICDs] and pacemakers [PMs]), the potential risk of suddenly being unable to drive, and hence of causing road accidents, is higher than in the general population.
Isolated left ventricular non-compaction (LVNC) is a rare genetic form of cardiomyopathy (CM) characterized by prominent left ventricular wall trabeculation and intertrabecular recesses communicating with the ventricular cavity.
Whether early vs. delayed referral to septal reduction therapies (SRT, alcohol septal ablation or surgical myectomy) bears prognostic relevance in hypertrophic obstructive cardiomyopathy (HOCM) is unresolved.
In severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM) and mild septal hypertrophy, mitral valve (MV) abnormalities may play an important role in MV displacement into the left ventricular (LV) outflow tract.
In patients with hypertrophic cardiomyopathy (HCM), left ventricular outflow tract obstruction is the expression of a true pathophysiological conspiracy, the end result of which is as elegant as it is diabolical, a puzzle that took early investigators, including Eugene Braunwald, over a decade to solve.
More than 20 years have passed since the discovery of the first sarcomeric gene associated with the onset of hypertrophic cardiomyopathy (HCM). During this time, the development of modern human genome sequencing technologies, combined with growing knowledge of genetics, have made a specific genetic test for HCM available for diagnostic purposes and widely available in many countries.
Progressive heart failure associated with left ventricular remodeling and systo-diastolic dysfunction is one of the most severe complications of hypertrophic cardiomyopathy (HCM). Such condition, for the lack of a better term, is referred to as end-stage (ES) HCM.
